Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Craniofacial Abnormalities

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Craniofacial Abnormalities in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Craniofacial Abnormalities: Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenberger, G1
Meien, S1
Kutsche, K1
Bögel, G1
Gujdár, A1
Geiszt, M1
Lányi, Á1
Fekete, A1
Sipeki, S1
Downward, J1
Buday, L1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Craniofacial Abnormalities

ArticleYear
Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome.
    Human mutation, 2009, Volume: 30, Issue:3

    Topics: Abnormalities, Multiple; Cells, Cultured; Chromones; Craniofacial Abnormalities; Enzyme Inhibitors;

2009
Frank-ter Haar syndrome protein Tks4 regulates epidermal growth factor-dependent cell migration.
    The Journal of biological chemistry, 2012, Sep-07, Volume: 287, Issue:37

    Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Movement; Chlorocebus aethiops; Chromones; COS C

2012